SENTI BIOSCIENCES Files Amended Terms for Senior Secured Convertible Notes

An 8-K discloses a revised form of senior secured convertible note maturing November 23, 2026, repayable in cash at 200% of outstanding principal.

Share
Senti Biosciences develops gene circuit-based cell therapies.